Table Graph
      published meta-analysis   sensitivity analysis   studies

bromhexine in COVID-19 prophylaxis (excluding children) - Summary of results

OutcomeTE95% CInkI2ROBPub. bias deathsdetailed resultsMikhaylov, 2021 1.00 [0.02; 52.45] 1.00[0.02; 52.45]Mikhaylov, 202110%50NAnot evaluable hospitalizationdetailed resultsMikhaylov, 2021 0.23 [0.01; 5.48] 0.23[0.01; 5.48]Mikhaylov, 202110%50NAnot evaluable new illness compatible with Covid-19 detailed resultsMikhaylov, 2021 0.22 [0.04; 1.21] 0.22[0.04; 1.21]Mikhaylov, 202110%50NAnot evaluable ICU admissiondetailed resultsMikhaylov, 2021 1.00 [0.02; 52.45] 1.00[0.02; 52.45]Mikhaylov, 202110%50NAnot evaluable0.02.01.0relative treatment effectwww.metaEvidence.org2024-04-25 14:57 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 89 - treatments: 688 - roots T: 290

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons